Search Results - "Aoe, K."

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma by Yamamoto, J, Ohnuma, K, Hatano, R, Okamoto, T, Komiya, E, Yamazaki, H, Iwata, S, Dang, N H, Aoe, K, Kishimoto, T, Yamada, T, Morimoto, C

“…Background: Malignant pleural mesothelioma (MPM) is an aggressive neoplasm arising from mesothelial lining of pleura. CD26 molecules preferentially expressed…”
Get full text

Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion by Murata, Y., Aoe, K., Mimura‐Kimura, Y., Murakami, T., Oishi, K., Matsumoto, T., Ueoka, H., Matsunaga, K., Yano, M., Mimura, Y.

“…Summary The cause of pleural effusion remains uncertain in approximately 15% of patients despite exhaustive evaluation. As recently described immunoglobulin…”
Get full text

Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan by Nojiri, Shuko, Gemba, Kenichi, Aoe, Keisuke, Kato, Katsuya, Yamaguchi, Takuhiro, Sato, Tsugumichi, Kubota, Kiyoshi, Kishimoto, Takumi

“…The objective in our study was to examine baseline and other characteristics associated with survival in patients with malignant pleural mesothelioma in Japan…”
Get full text

3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy by Kasahara, K, Kiura, K, Nogami, N, Takayama, K, Takiguchi, Y, Hirashima, T, Aoe, K, Hayashi, H, Saka, H, Takahashi, K, Imamura, F, Oizumi, S, Inoue, A, Satouchi, M, Tatsumi, M, Nakamura, T, Enatsu, S, Tamura, T, Nakagawa, K

Get full text

Radical Cyclization in Heterocycle Synthesis. 11. A Novel Synthesis of α,β-Disubstituted γ-Lactones via Sulfanyl Radical Addition−Cyclization Using Hydroximates as a Tether by Miyata, Okiko, Nishiguchi, Atsuko, Ninomiya, Ichiya, Aoe, Keiichi, Okamura, Kimio, Naito, Takeaki

“…A combination of sulfanyl radical addition−cyclization of dienes connected with hydroximates and subsequent conversion of the resulting cyclic hydroximate to…”
Get full text

Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion by HIRAKI, A, AOE, K, MATSUO, K, MURAKAMI, K, MURAKAMI, T, ONODA, T. T, SUGI, K, TAKEYAMA, T. H, EDA, R

“…OBJECTIVE: Tuberculosis, the leading cause of death among infectious diseases worldwide, is a major cause of lymphocytic exudative pleural effusion. T-helper 1…”
Get full text

1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001 by Fujimoto, N., Kozuki, T., Aoe, K., Miyamoto, Y., Wada, S., Harada, D., Yoshida, M., Sakurai, J., Hotta, K.

Get full text

1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma by Hayashi, H., Okada, M., Kijima, T., Aoe, K., Kato, T., Fujimoto, N., Nakagawa, K., Takeda, Y., Hida, T., Kanai, K., Hirano, J., Namba, Y., Ohe, Y.

Get full text

Identification of FC/TA-891 and its metabolite, FCE22101 by high performance liquid chromatography - atmospheric pressure chemical ionization mass spectrometry using bromoform by HORIMOTO, S, MAYUMI, T, AOE, K, NISHIMURA, N

Get full text

Effect of nozzle shape and operating conditions on resuspension of single particles by an impinging air jet by Gotoh, K., Aoe, K., Nishimura, T.

Get full text

SIOG2024-4-OA-048 Enhancing geriatric assessment implementation in Japan: insights from the ENSURE-GA study by Kuyama, S., Aoe, K., Inoue, M., Shoda, H., Kurata, T., Sasaki, T., Sugano, K., Shinomiya, S., Hamada, N., Yamamoto, S., Takita, K., Nishioka, Y., Kobayashi, K., Isobe, T., Tsubata, Y.

Get full text

Evaluation of quality of life in survivors with malignant pleural mesothelioma in Japan by Oze, I., Nagamatsu, Y., Aoe, K., Hotta, K., Kato, K., Nakagawa, J., Hara, K., Kishimoto, T., Fujimoto, N.

Get full text

Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.

Get full text

1525PUpdated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T, Nogami, N, Kozuki, T, Harada, D, Kubo, T, Ohashi, K, Kuyama, S, Kudo, K, Bessho, A, Fujimoto, N, Aoe, K, Shibayama, T, Minami, D, Sugimoto, K, Ochi, N, Takigawa, N, Hotta, K, Kiura, K

“…Abstract Background In a phase I study, Afa (30 mg/body daily) plus Bev (15 mg/kg every 3 weeks) was well tolerated and had evidence of favorable disease…”
Get full text

1525P - Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.

“…In a phase I study, Afa (30mg/body daily) plus Bev (15mg/kg every 3 weeks) was well tolerated and had evidence of favorable disease control (Lung Cancer,…”
Get full text

A phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Harada, D., Nogami, N., Kozuki, T., Ninomiya, T., Bessho, A., Kuyama, S., Fujimoto, N., Sugimoto, K., Aoe, K., Ochi, N., Minami, D., Fukamatsu, N., Kudo, K., Kiura, K.

Get full text

A large prospective cohort study of the clinical features of advanced lung cancer harboring HER2 aberrations (HER2-CS STUDY) by Tanaka, T., Yoshioka, H., Bessho, A., Ishikawa, N., Yamasaki, M., Shibayama, T., Aoe, K., Kozuki, T., Fujimoto, N., Genba, K., Ueda, Y., Inoue, M., Murakami, T., Kuyama, S., Kawai, H., Fujitaka, K., Inoue, K., Takata, M., Yanai, H., Kiura, K.

Get full text

D23 MOONRAKER: DIAGNOSIS AND MANAGEMENT OF THE PLEURAL SPACE: Involvement Of Igg4 In Pleural Effusions Of Unknown Cause by Murata, Y, Aoe, K, Murakami, T, Oishi, K, Matsumoto, T, Ueoka, H, Mimura, Y

Get full text

Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay by ASANO, Hiroaki, TOYOOKA, Shinichi, HIRAKI, Akio, SUGI, Kazuro, KIURA, Katsuyuki, DATE, Hiroshi, SHIMIZU, Nobuyoshi, TOKUMO, Masaki, ICHIMURA, Kouichi, AOE, Keisuke, ITO, Sachio, TSUKUDA, Kazunori, OUCHIDA, Mamoru, AOE, Motoi, KATAYAMA, Hideki

“…Purpose: Mutations in the epidermal growth factor receptor ( EGFR ) gene have been reported to be present in non–small cell lung cancer (NSCLC) and related to…”
Get full text

A case report of a mediastinal bronchogenic cyst with back pain by Umemori, Y, Kotani, K, Makihara, S, Aoe, K

“…We performed thoracoscopic surgery for a mediastinal bronchogenic cyst with complaining of back pain. The patient, a 38-year-old male, was admitted with an…”
Get more information